StockTake: EBR Systems first implant is a strategic milestone

EBR Systems enrols their first patient and implant in the Totally Leadless CRT study for newly diagnosed heart failure patients at the Princess Alexandra Hospital, Brisbane.

Stockhead’s Fraser Palamara looks at EBR Systems (ASX:EBR) latest news, as the company enrols its first patient and implant in the Totally Leadless CRT study for newly diagnosed heart failure patients at the Princess Alexandra Hospital, Brisbane. The study will evaluate this approach in a group that makes up roughly 75% of the CRT market.

This video was developed in collaboration with EBR Systems, a Stockhead client at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.

Originally published as StockTake: EBR Systems first implant is a strategic milestone